Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Infectious Disease Drugs Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Antibacterials
    • 1.4.3 Antiviral drugs
    • 1.4.4 Antiparasitic drugs
    • 1.4.5 Antifungal
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Infectious Disease Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 HIV
    • 1.5.3 Malaria
    • 1.5.4 Hepatitis
    • 1.5.5 Influenza
    • 1.5.6 HPV
    • 1.5.7 Tuberculosis
    • 1.5.8 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Drugs Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Infectious Disease Drugs Industry
      • 1.6.1.1 Infectious Disease Drugs Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Infectious Disease Drugs Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Infectious Disease Drugs Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Infectious Disease Drugs Market Perspective (2015-2026)
  • 2.2 Infectious Disease Drugs Growth Trends by Regions
    • 2.2.1 Infectious Disease Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Infectious Disease Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Infectious Disease Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Infectious Disease Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Infectious Disease Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Infectious Disease Drugs Players by Market Size
    • 3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Infectious Disease Drugs Market Concentration Ratio
    • 3.2.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2019
  • 3.3 Infectious Disease Drugs Key Players Head office and Area Served
  • 3.4 Key Players Infectious Disease Drugs Product Solution and Service
  • 3.5 Date of Enter into Infectious Disease Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Infectious Disease Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Drugs Breakdown Data by Application (2015-2026)

  • 5.1 Global Infectious Disease Drugs Market Size by Application (2015-2020)
  • 5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Infectious Disease Drugs Market Size (2015-2020)
  • 6.2 Infectious Disease Drugs Key Players in North America (2019-2020)
  • 6.3 North America Infectious Disease Drugs Market Size by Type (2015-2020)
  • 6.4 North America Infectious Disease Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Infectious Disease Drugs Market Size (2015-2020)
  • 7.2 Infectious Disease Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Infectious Disease Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Infectious Disease Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Infectious Disease Drugs Market Size (2015-2020)
  • 8.2 Infectious Disease Drugs Key Players in China (2019-2020)
  • 8.3 China Infectious Disease Drugs Market Size by Type (2015-2020)
  • 8.4 China Infectious Disease Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Infectious Disease Drugs Market Size (2015-2020)
  • 9.2 Infectious Disease Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Infectious Disease Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Infectious Disease Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Infectious Disease Drugs Market Size (2015-2020)
  • 10.2 Infectious Disease Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Infectious Disease Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Infectious Disease Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Infectious Disease Drugs Market Size (2015-2020)
  • 11.2 Infectious Disease Drugs Key Players in India (2019-2020)
  • 11.3 India Infectious Disease Drugs Market Size by Type (2015-2020)
  • 11.4 India Infectious Disease Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Infectious Disease Drugs Market Size (2015-2020)
  • 12.2 Infectious Disease Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Infectious Disease Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Infectious Disease Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 GlaxoSmithKline
    • 13.1.1 GlaxoSmithKline Company Details
    • 13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
    • 13.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2015-2020))
    • 13.1.5 GlaxoSmithKline Recent Development
  • 13.2 Gilead Sciences
    • 13.2.1 Gilead Sciences Company Details
    • 13.2.2 Gilead Sciences Business Overview and Its Total Revenue
    • 13.2.3 Gilead Sciences Infectious Disease Drugs Introduction
    • 13.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.2.5 Gilead Sciences Recent Development
  • 13.3 Merck & Co.
    • 13.3.1 Merck & Co. Company Details
    • 13.3.2 Merck & Co. Business Overview and Its Total Revenue
    • 13.3.3 Merck & Co. Infectious Disease Drugs Introduction
    • 13.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.3.5 Merck & Co. Recent Development
  • 13.4 Pfizer
    • 13.4.1 Pfizer Company Details
    • 13.4.2 Pfizer Business Overview and Its Total Revenue
    • 13.4.3 Pfizer Infectious Disease Drugs Introduction
    • 13.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.4.5 Pfizer Recent Development
  • 13.5 Sanofi
    • 13.5.1 Sanofi Company Details
    • 13.5.2 Sanofi Business Overview and Its Total Revenue
    • 13.5.3 Sanofi Infectious Disease Drugs Introduction
    • 13.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.5.5 Sanofi Recent Development
  • 13.6 AbbVie
    • 13.6.1 AbbVie Company Details
    • 13.6.2 AbbVie Business Overview and Its Total Revenue
    • 13.6.3 AbbVie Infectious Disease Drugs Introduction
    • 13.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.6.5 AbbVie Recent Development
  • 13.7 Shire
    • 13.7.1 Shire Company Details
    • 13.7.2 Shire Business Overview and Its Total Revenue
    • 13.7.3 Shire Infectious Disease Drugs Introduction
    • 13.7.4 Shire Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.7.5 Shire Recent Development
  • 13.8 Grifols
    • 13.8.1 Grifols Company Details
    • 13.8.2 Grifols Business Overview and Its Total Revenue
    • 13.8.3 Grifols Infectious Disease Drugs Introduction
    • 13.8.4 Grifols Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.8.5 Grifols Recent Development
  • 13.9 Johnson & Johnson
    • 13.9.1 Johnson & Johnson Company Details
    • 13.9.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
    • 13.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.9.5 Johnson & Johnson Recent Development
  • 13.10 Protein Sciences
    • 13.10.1 Protein Sciences Company Details
    • 13.10.2 Protein Sciences Business Overview and Its Total Revenue
    • 13.10.3 Protein Sciences Infectious Disease Drugs Introduction
    • 13.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2015-2020)
    • 13.10.5 Protein Sciences Recent Development
  • 13.11 AstraZeneca
    • 10.11.1 AstraZeneca Company Details
    • 10.11.2 AstraZeneca Business Overview and Its Total Revenue
    • 10.11.3 AstraZeneca Infectious Disease Drugs Introduction
    • 10.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2015-2020)
    • 10.11.5 AstraZeneca Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Infectious Disease Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    GlaxoSmithKline
    Gilead Sciences
    Merck & Co.
    Pfizer
    Sanofi
    AbbVie
    Shire
    Grifols
    Johnson & Johnson
    Protein Sciences
    AstraZeneca

    Market segment by Type, the product can be split into
    Antibacterials
    Antiviral drugs
    Antiparasitic drugs
    Antifungal
    Others
    Market segment by Application, split into
    HIV
    Malaria
    Hepatitis
    Influenza
    HPV
    Tuberculosis
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Infectious Disease Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Infectious Disease Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Infectious Disease Drugs are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now